A vaccine made by Pfizer could seek emergency approval by the third week of November, but it likely won’t be available to the public until mid- to late 2021
-- Read more on ScientificAmerican.com
More...
A vaccine made by Pfizer could seek emergency approval by the third week of November, but it likely won’t be available to the public until mid- to late 2021
-- Read more on ScientificAmerican.com
More...